Quantcast

Latest Renal cell carcinoma Stories

2014-05-31 08:21:17

Data Support Adoption of Stable Disease as Response Criterion, Raise Intriguing Hypotheses about Sequential Therapy and Utility of IL-2 as Salvage Option CHICAGO, May 31, 2014 /PRNewswire/

2014-05-30 11:21:45

Reduced kidney function may increase the risk of developing kidney and urothelial cancers.

2014-05-30 08:25:14

Retrospective Analysis Demonstrates Survival Benefits for Patients with Stable and Progressive Disease after HD IL-2 in the Modern Era Suggesting Appropriate Drug Sequencing May Improve Outcomes

2014-05-28 08:31:42

LAUSANNE, Switzerland, May 28, 2014 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that

2014-05-14 16:29:06

WHIPPANY, N.J., May 14, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc.

2014-05-06 23:01:41

Retrospective Study of Roswell Park Patients Documents Safety and Benefit of Complex Immunotherapy Buffalo, NY (PRWEB) May 06, 2014 A retrospective study

2014-05-05 20:23:52

LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

2014-05-02 23:06:53

Minimally Invasive Procedure Showcases Future Treatment Options Pleasanton, CA (PRWEB) May 02, 2014 Sanarus Technologies welcomes the release of an abstract

2014-04-23 20:23:23

WHIPPANY, N.J. and THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., April 23, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc.

2014-04-15 23:10:44

A new study published in The Oncologist journal shows that a subset of patients with advanced differentiated thyroid cancer (DTC) and multiple comorbidities in which full-dose sorafenib is considered


Word of the Day
bowerly
  • Large; stout; burly.
The word 'bowerly' is an alteration of 'burly'.